Volume 7, Issue 1 (2-2025)
pbp 2025, 7(1): 10-18 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kaveh M, Tayyeb Ghasemi S. Association between Serum Vitamin D Level and Uterine Leiomyomas: A Case-Control Study. pbp 2025; 7 (1) :10-18
URL: http://pbp.medilam.ac.ir/article-1-257-en.html
URL: http://pbp.medilam.ac.ir/article-1-257-en.html
1- Department Of Obstetrics And Gynecology, School Of Medicine, Amir Al Momenin Hospital Zabol University Of Medical Sciences, Zabol, Iran
2- Department Of Obstetrics And Gynecology, School Of Medicine, Amir Al Momenin Hospital Zabol University Of Medical Sciences, Zabol, Iran ,shilagasemi1353@gmail.com
2- Department Of Obstetrics And Gynecology, School Of Medicine, Amir Al Momenin Hospital Zabol University Of Medical Sciences, Zabol, Iran ,
Abstract: (344 Views)
Objective: Uterine fibroids (UFs) is a benign disorder that affects women of reproductive age. Vitamin D is thought to play an important role in regulating cell proliferation and differentiation. This study aimed to investigate the role of vitamin D in uterine fibroid-related problems.
Methods: This case control study was done on 72 women with fibroid lesion (case group) who referred to Amir-al Momenin hospital, Zabol, Iran between April 2022 and December 2022. Moreover, 38 women with normal uterine morphology on ultrasonography were considered control group within the age range of 20 to 45 years. Blood samples were taken for measuring 25-hydroxyvitamin D levels. Demographic and other related clinical information were collected from the patients.
Result: The ratio of BMI in the case group (73.52%) was higher than the control group (63.15%). This difference was statistically significant (P=0.002). Vitamin D deficiency was common in the case group (54.90%) as compared to controls (6.7%) while sufficiency was common among controls (67.8% vs. 27.45%); the difference was statistically significant (p < 0.05). Women in the control group were exposed to sunlight more often than case group which was statistically significant (P=0.002). Women with uterine fibroids, 94.11% had low exposure to sunlight compared to women in the control group (73.68%), which was statistically significant (P=0.002). Ten patients (13.88%) of case group mentioned a family history of uterine fibroids, while none of the women in the control group had this item. This difference was statistically significant (P=0.014).
Conclusion: The present study showed that patients with UFs had significantly lower serum levels of vitamin D. Vitamin D deficiency is a potential risk factor for UFs.
Methods: This case control study was done on 72 women with fibroid lesion (case group) who referred to Amir-al Momenin hospital, Zabol, Iran between April 2022 and December 2022. Moreover, 38 women with normal uterine morphology on ultrasonography were considered control group within the age range of 20 to 45 years. Blood samples were taken for measuring 25-hydroxyvitamin D levels. Demographic and other related clinical information were collected from the patients.
Result: The ratio of BMI in the case group (73.52%) was higher than the control group (63.15%). This difference was statistically significant (P=0.002). Vitamin D deficiency was common in the case group (54.90%) as compared to controls (6.7%) while sufficiency was common among controls (67.8% vs. 27.45%); the difference was statistically significant (p < 0.05). Women in the control group were exposed to sunlight more often than case group which was statistically significant (P=0.002). Women with uterine fibroids, 94.11% had low exposure to sunlight compared to women in the control group (73.68%), which was statistically significant (P=0.002). Ten patients (13.88%) of case group mentioned a family history of uterine fibroids, while none of the women in the control group had this item. This difference was statistically significant (P=0.014).
Conclusion: The present study showed that patients with UFs had significantly lower serum levels of vitamin D. Vitamin D deficiency is a potential risk factor for UFs.
Type of Study: Research |
Subject:
Green Chemistry
Received: 2024/07/28 | Accepted: 2024/09/26 | Published: 2025/02/28
Received: 2024/07/28 | Accepted: 2024/09/26 | Published: 2025/02/28
References
1. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.[J] .Obstet Gynecol. 2021;137: e100-e115.doi:10.1097/AOG.0000000000004401
2. Csatlos E, Rigó J Jr, Szabó I,et al. . [Uterine leiomyoma]. Orv Hetil. 2010;151(42):1734–1741. Hungarian. doi: 10.1556/OH.2010.28977.
3. Beroukhim G, Mahabamunuge J, Pal L. Racial disparities in access to reproductive health and fertility care in the United States.[J] .Curr Opin Obstet Gynecol. 2022;34: 138-146. DOI: 10.1097/GCO.0000000000000780
4. Ciebiera M, Włodarczyk M, Ciebiera M, et al. Vitamin D and Uterine Fibroids-Review of the Literature and Novel Concepts.[J] .Int J Mol Sci. 2018;19: undefined. doi: 10.3390/ijms19072051.
5. Baird D D, Hill M C, Schectman J M, et al. Vitamin d and the risk of uterine fibroids. Epidemiology. 2013; 24 (3): 447–453. doi:10.1097/EDE. 0b013e31828acca0
6. Szydłowska I, Nawrocka-Rutkowska J, Brodowska A, et al. Dietary natural compounds and vitamins as potential cofactors in uterine fibroids growth and development. Nutrients. 2022;14(4):734. doi: 10.3390/nu14040734.
7. Kumari R, Nath B, Gaikwad HS, et al. Association between serum vitamin D level and uterine fibroid in premenopausal women in Indian population. Drug Discov Ther. 2022;16(1):8-13. doi: 10.5582/ddt.2021.01019.
8. Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp. Mol. Med. 2018;50(4):1-4. doi: 10.1038/s12276-018-0038-9.
9. Ferrer-Mayorga G, Larriba MJ, Crespo P, et al. Mechanisms of action of vitamin D in colon cancer. J Steroid Biochem Mol Biol. 2019;185:1-6. doi: 10.1016/j.jsbmb.2018.07.002.
10. Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211-e1. doi: 10.1016/j.ajog.2011.12.002.
11. Vilos GA, Allaire C, Laberge PY, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157-78. DOI: 10.1016/S1701-2163(15)30338-8.
12. Lerchbaum E, Rabe T. Vitamin D and female fertility. Curr Opin Gynecol Obstet. 2014;26(3):145-50. DOI: 10.1097/GCO.0000000000000065
13. Li S, Chen B, Sheng B, et al. The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: a case-controlled study. Journal of International Medical Research. 2020 May;48(5):0300060520923492. doi: 10.1177/0300060520923492
14. Wu J L, Segars J H. Is vitamin D the answer for prevention of uterine fibroids? Fertil. Steril. 2015;104:559–560. doi: 10.1016/j.fertnstert.2015.06.034.
15. Ciebiera M, Lukaszuk K, Meczekalski B, et al. Alternative oral agents in prophylaxis and therapy of uterine fibroids-an up-to-date review. Int. J. Mol. Sci. 2017;18 doi: 10.3390/ijms18122586.
16. Brakta S, Diamond J S, Al-Hendy A, et al. Role of vitamin D in uterine fibroid biology. Fertil. Steril. 2015;104:698–706. doi: 10.1016/j.fertnstert.2015.05.031.
17. Odhaib SA, Alibrahim NT, Zaboon IA, et al. Vitamin D Metabolic Profiles in Premenopausal Women Wearing Niqab and Hijab in Sunny Basrah. Cureus. 2021;13(5):e14909. doi: 10.7759/cureus.14909.
18. Hussain T, Eimal Latif AH, Malik S, et al. Vitamin D Deficiency and Associated Risk Factors in Muslim Housewives of Quetta, Pakistan: A Cross-Sectional Study. Cureus. 2021;13(9):e17643. doi: 10.7759/cureus.17643.
19. Li S, Chen B, Sheng B, Wang J, Zhu X. The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: a case-controlled study. J Int Med Res. 2020 May;48(5):300060520923492. doi: 10.1177/0300060520923492.
20. Płudowski P, Kos-Kudła B, Walczak M, et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023;15(3):695. doi: 10.3390/nu15030695.
21. Mendes MA, da Silva I, Ramires V, et al. Metabolic equivalent of task (METs) thresholds as an indicator of physical activity intensity. PLoS One. 2018;13(7):e0200701. https://doi.org/10.1371/journal.pone.0200701 PMid:30024953.
22. Humayun Q, Iqbal R, Azam I, et al. Development and validation of sunlight exposure measurement questionnaire (SEM-Q) for use in adult population residing in Pakistan. BMC Public Health. 2012;12:421. https:// doi.org/10.1186/1471-2458-12-421 PMid:22682277
23. Koli V. SIGNIFICANCE OF PSYCHOLOGY IN OBSTETRICS AND GYNAECOLOGY. J. Res. Educ. Sci. 2023;4(TMA Conference):978-81.
24. Vergara D, Catherino WH, Trojano G, Tinelli A. Vitamin D: Mechanism of action and biological effects in uterine fibroids. Nutrients. 2021;13(2):597. doi: 10.3390/nu13020597.
25. McKain L, Edsall K, Dufour R, Lickert C. Treatment Patterns in Patients with Uterine Fibroids With and Without a Diagnosis of Heavy Menstrual Bleeding: Results from a Large US Claims Database. J Womens Health. 2023;32(3):332-40. doi: 10.1089/jwh.2022.0056.
26. Datir SG, Bhake A, Datir II SG. Management of uterine fibroids and its complications during pregnancy: a review of literature. Cureus. 2022;14(11). doi: 10.7759/cureus.31080.
27. Muawad R, Dabbagh R, Sabr Y. Association of health and lifestyle factors with uterine fibroids among Saudi women: A case–control study. J. Taibah Univ. Medical Sci. 2022;17(6):1039-46. doi: 10.1016/j.jtumed.2022.06.005.
28. Lovett SM, Sandler DP, O’Brien KM. Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study. JNCI: J Natl Cancer Inst 2023;115(6):662-70. doi: 10.1093/jnci/djad038.
29. Ciebiera M, Włodarczyk M, Słabuszewska-Jóźwiak A, et al. Influence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroids. Fertil. Steril. 2016;106(7):1787-92. DOI: 10.1016/j.fertnstert.2016.09.007.
30. Pavone D, Clemenza S, Sorbi F, et al. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3-11. doi: 10.1016/j. bpobgyn.2017.09.004.
31. Machado-Lopez A, Simón C, Mas A. Molecular and Cellular Insights into the Development of Uterine Fibroids. Int J Mol Sci. 2021 Aug 6;22(16):8483. doi: 10.3390/ijms22168483.
32. Farzaneh F, Sadeghi K, Chehrazi M. Vitamin D Status in Women with Uterine Fibroids: A Cross-sectional Study. Maced. J. Med. Sci. 2020; 8(B):109-113. doi.org/10.3889/oamjms.2020.3863
33. Sabry M, Halder SK, Allah AS, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. Int J Womens Health. 2013;5:93-100. doi: 10.2147/IJWH.S38800.
34. Halder SK, Sharan C, Al-Hendy A. 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod. 2012;86(4):116. doi: 10.1095/biolreprod.111.098145.
35. Gong L, Liu M, Shi H, et al. Uterine fibroids are associated with increased risk of pre-eclampsia: A case-control study. Front. cardiovasc. med. 2022;9:1011311. doi: 10.3389/fcvm.2022.1011311.
36. Al-Hendy A, Diamond MP, Boyer TG, et al. Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells. J Clin Endocrinol Metab. 2016;101(4):1542-51. doi: 10.1210/jc.2015-3555.
37. Ciebiera M, Ali M, Prince L, et al. The significance of measuring vitamin D serum levels in women with uterine fibroids. Reprod Sci. 2021;28:2098-109. DOI: 10.1007/s43032-020-00363-8
38. Kaplan O, Asli Z; Yasemin T et al. 25-Hydroxy vitamin D levels in premenopausal Turkish women with uterine leiomyoma. Gynecol. Endocrinol. 2017; 1–4. doi:10.1080/09513590.2017.1391774.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |